Cytori to Webcast Year End Financial Results March 8
23 févr. 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Feb 23, 2012) - Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its fourth quarter and year end financial results and business update on Thursday,...
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
30 janv. 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Jan 30, 2012) - Cytori Therapeutics (NASDAQ: CYTX) has received an Investigational Device Exemption (IDE) approval from the U.S. FDA to begin the ATHENA trial. ATHENA...
Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function
24 janv. 2012 07h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Jan 24, 2012) - Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of previously reported six-month outcomes from APOLLO, the Company's European...
Cytori Announces Presentations at Biotech Showcase on Jan 9th and 10th
05 janv. 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Jan 5, 2012) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) will webcast their corporate presentation at the Biotech Showcase at 4:00 PM PT on Monday, January 9 in San...
Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System
19 déc. 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Dec 19, 2011) - Cytori Therapeutics (NASDAQ: CYTX) filed its Investigational Device Exemption (IDE) application to begin a clinical trial of the Company's...
Cytori's Celution(R) One Receives European CE Mark Approval
30 nov. 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Nov 30, 2011) - Cytori's (NASDAQ: CYTX) Celution® One System, the next-generation device of the Company's Celution® platform, has been granted CE Mark...
Cytori Therapeutics Announces Participation in the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum
28 nov. 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Nov 28, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will present at the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum on December 1. In addition, CEO...
Cytori to Webcast Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011
10 nov. 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Nov 10, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) will webcast their corporate presentation at the Lazard Capital Markets 8th Annual Healthcare Conference at...
Cytori Reports Third Quarter Business Update and Financial Results
03 nov. 2011 16h05 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Nov 3, 2011) - Cytori Therapeutics (NASDAQ: CYTX) today is reporting its third quarter 2011 business update and financial results.
Product revenues for the third...
Cytori to Webcast Third Quarter Financial Results November 3
26 oct. 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Oct 26, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and quarterly business update on Thursday,...